ArticleOncotarget2015

Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.

Yi-Te Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.